UW Bioengineering
Fast Facts
News and Events
Building innovation through mentorship
In the rapidly evolving field of bioengineering, the bridge between [...]
Events
A new platform for more effective cancer drug testing using aptamer sensors
UW BioE researchers led by Tran Nguyen, post-doctoral fellow with the Albert Folch lab, has developed a new platform that uses microdissected tumor biopsies.
Paul Yager receives funding to develop low-cost at-home testing to monitor chronic diseases
Paul Yager has been awarded a Washington Research Foundation Phase 1 commercialization grant to support his groundbreaking work in paper-based microfluidics.
Kelly Stevens receives the BMES 2024 Mid-Career Award
Congratulations to UW Bioengineering Associate Professor Kelly Stevens for being honored with the Biomedical Engineering Society (BMES) 2024 Mid-Career Award.
Featured Publications
Injectable Biodegradable Chitosan-Alginate 3D Porous Gel Scaffold for mRNA Vaccine Delivery
https://onlinelibrary.wiley.com/doi/full/10.1002/mabi.201800242 Jingxuan Yan, Ruying Chen, Hong Zhang, James D. Bryers. Macromol Biosci. 2019 Feb;19(2):e1800242. doi: 10.1002/mabi.201800242. Abstract: [...]
Time of flight secondary ion mass spectrometry—A method to evaluate plasma-modified three-dimensional scaffold chemistry
Research Associate Professor Lara Gamble and colleagues report on a technique for characterizing the distribution and composition of chemical species through complex porous scaffolds. This approach could be widely applicable for ToF-SIMS analysis of scaffolds modified by multiple plasma processing techniques as well as alternative surface modification approaches.
Engineering a multicellular vascular niche to model hematopoietic cell trafficking
Assistant Professor Ying Zheng and colleagues developed an engineered human vascular marrow niche to examine the three-dimensional cell interactions that direct hematopoietic cell trafficking. The platform provides a tool to advance study of the interactions between endothelial cells, marrow-derived fibroblasts and hematopoeitic cells that comprise the marrow vascular niche, and has potential for use in testing therapeutics and personalized medicine.
